(Q41332602)

29 September 2017

1 reference

title

Advances in the development and evaluation of bovine herpesvirus 1 vaccines (English)

1 reference

29 September 2017

bovine herpesvirus 1

1 reference

van Oirschot JT

1

1 reference

29 September 2017

Kaashoek MJ

series ordinal

2

1 reference

29 September 2017

Rijsewijk FA

series ordinal

3

1 reference

29 September 2017

language of work or name

1 reference

1 November 1996

1 reference

29 September 2017

Veterinary Microbiology

1 reference

29 September 2017

53

1 reference

29 September 2017

1-2

1 reference

29 September 2017

43-54

1 reference

Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA.

29 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2896%2901233-3

7 January 2021

Experimental quantification of vaccine-induced reduction in virus transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2896%2901233-3

7 January 2021

Effects of formalin inactivation on bovine herpes virus-1 glycoproteins and antibody response elicited by formalin-inactivated vaccines in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2896%2901233-3

7 January 2021

Efficacy of a deletion mutant bovine herpesvirus-1 (BHV-1) vaccine that allows serologic differentiation of vaccinated from naturally infected animals

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2896%2901233-3

7 January 2021

Double blind field evaluation of a trivalent vaccine against respiratory disease in veal calves

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2896%2901233-3

7 January 2021

Safety and efficacy of live and inactivated infectious bovine rhinotracheitis vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2896%2901233-3

7 January 2021

Truncated bovine herpesvirus-1 glycoprotein I (gpI) initiates a protective local immune response in its natural host

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2896%2901233-3

7 January 2021

Persistent infection of the genital tract and excretion of the vaccine strain after live virus immunization with bovine herpesvirus 1 (IBR/IPV virus).

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2896%2901233-3

7 January 2021

Direct and indirect effects in vaccine efficacy and effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2896%2901233-3

7 January 2021

Multiple administration with interleukin-2 potentiates antigen-specific responses to subunit vaccination with bovine herpesvirus-1 glycoprotein IV

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2896%2901233-3

7 January 2021

A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2896%2901233-3

7 January 2021

An inactivated vaccine based on a glycoprotein E-negative strain of bovine herpesvirus 1 induces protective immunity and allows serological differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2896%2901233-3

7 January 2021

Persistence of antibodies against bovine herpesvirus 1 and virus reactivation two to three years after infection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2896%2901233-3

7 January 2021

Thymidine kinase-negative bovine herpesvirus type 1 mutant is stable and highly attenuated in calves

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2896%2901233-3

7 January 2021

Bovine herpesvirus-1 (infectious bovine rhinotracheitis virus)-based viral vector which expresses foot-and-mouth disease epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2896%2901233-3

7 January 2021

Blocking ELISA for distinguishing infectious bovine rhinotracheitis virus (IBRV)-infected animals from those vaccinated with a gene-deleted marker vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2896%2901233-3

7 January 2021

Heat-shock promoter-driven synthesis of secreted bovine herpesvirus glycoproteins in transfected cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2896%2901233-3

7 January 2021

An in vivo study of a glycoprotein gIII-negative bovine herpesvirus 1 (BHV-1) mutant expressing beta-galactosidase: evaluation of the role of gIII in virus infectivity and its use as a vector for mucosal immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2896%2901233-3

7 January 2021

Isolation of the infectious bovine rhinotracheitis virus

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2896%2901233-3

7 January 2021

Selection of European Union standard reference sera for use in the serological diagnosis of infectious bovine rhinotracheitis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2896%2901233-3

7 January 2021

Immunopotentiation of bovine respiratory disease virus vaccines by interleukin-1 beta and interleukin-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2896%2901233-3

7 January 2021

Bovine herpesvirus-1 vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2896%2901233-3

7 January 2021

A subunit gIV vaccine, produced by transfected mammalian cells in culture, induces mucosal immunity against bovine herpesvirus-1 in cattle

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2896%2901233-3

7 January 2021

A glycoprotein E deletion mutant of bovine herpesvirus 1 is avirulent in calves

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2896%2901233-3

7 January 2021

A glycoprotein E deletion mutant of bovine herpesvirus 1 infects the same limited number of tissues in calves as wild-type virus, but for a shorter period

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1135%2896%2901233-3

7 January 2021

10.1016/S0378-1135(96)01233-3

Identifiers

DOI

1 reference

29 September 2017

1 reference